Published in Infect Immun on November 01, 1979
Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest (1986) 2.82
Regulation of murine macrophage Ia-antigen expression by products of activated spleen cells. J Exp Med (1980) 2.19
Regulation of macrophage accessory cell activity by mycobacteria. I. Ia expression in normal and irradiated mice infected with Mycobacterium microti. Clin Exp Immunol (1986) 0.89
Role of lipopolysaccharide in regulating colony-stimulating factor-dependent macrophage proliferation in vitro. Infect Immun (1980) 0.89
Prostaglandins in experimental syphilis: treponemes stimulate adherent spleen cells to secrete prostaglandin E2, and indomethacin upregulates immune functions. Infect Immun (1991) 0.84
Cyclic AMP inhibition of lipopolysaccharide-induced restriction of Legionella pneumophila growth in macrophage cultures. Infect Immun (1992) 0.78
In vitro suppression of myelopoiesis by adherent murine splenocytes in experimental disseminated histoplasmosis. Am J Pathol (1983) 0.75
Rabbit lymphocyte factors modulate prostaglandin biosynthesis in alveolar macrophages. Immunology (1985) 0.75
The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci (1966) 9.68
Human bone marrow colony growth in agar-gel. J Cell Physiol (1970) 5.82
Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry (1967) 4.22
Prostaglandins and thromboxanes. Annu Rev Biochem (1978) 3.47
Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages. J Exp Med (1978) 3.38
Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med (1977) 3.38
Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell (1976) 3.13
The induction of clones of normal mast cells by a substance from conditioned medium. Exp Cell Res (1966) 3.01
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
Acute antigen-induced elevation of serum colony stimulating factor (CFS) levels. Immunology (1971) 2.28
Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci U S A (1977) 1.96
Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production. J Exp Med (1978) 1.94
In vitro production of colony-stimulating activity. I. Exposure of mouse peritoneal cells to endotoxin. Cell Tissue Kinet (1974) 1.79
Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E. Science (1978) 1.60
Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. Science (1978) 1.51
The regulation of the immune response to T-independent antigens by prostaglandins and B cells. J Immunol (1976) 1.40
Modulation of hemopoiesis by prostaglandins. Exp Hematol (1977) 1.27
Effect of endotoxin on the production of colony-stimulating factor by human monocytes and macrophages. J Cell Physiol (1974) 1.23
Role of cyclic nucleotides in the proliferation of committed granulocyte-macrophage progenitor cells. Cancer Res (1977) 1.19
Defective prostaglandin synthesis by C3H/HeJ mouse macrophages stimulated with endotoxin preparations. Infect Immun (1979) 1.16
Immunostimulators induce granulocyte/macrophage colony-stimulating activity and block proliferation in a monocyte tumor cell line. J Exp Med (1977) 1.13
The role of prostaglandins in the control of the primary 19S immune response to sRBC. Cell Immunol (1977) 1.11
Colony-stimulating factor and inhibitor levels in acute granulocytic leukemia. Blood (1971) 1.00
Role of cyclic adenosine 3',5'-monophosphate in lymphocyte mitogenesis. J Immunol (1974) 0.98
Prostaglandins as regulators in cellular immunity. Prostaglandins Med (1978) 0.96
Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes. J Exp Med (1979) 0.96
Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. Cancer Res (1978) 0.93
Effect of prostaglandins on phagocytosis of sheep erythrocytes by mouse peritoneal macrophages. J Reticuloendothel Soc (1978) 0.93
Bone marrow colony-stimulating factor and tumor resistance-enhancing activity of postendotoxin mouse sera. Proc Natl Acad Sci U S A (1978) 0.88
The effects of prostaglandins on cAMP levels in subpopulations of mouse lymphocytes. Prostaglandins Med (1978) 0.83
Regulation of hemopoietic cell differentiation and proliferation. J Supramol Struct (1978) 0.82
Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate. J Biol Chem (1968) 7.13
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A (1987) 6.43
Perspectives on the basic reproductive ratio. J R Soc Interface (2005) 5.34
Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J Exp Med (1982) 5.33
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A (1981) 4.89
Human mononuclear leukocyte chemotaxis: a quantitative assay for humoral and cellular chemotactic factors. J Immunol (1972) 4.38
Effect of virus infections on the function of the immune system. Annu Rev Microbiol (1970) 4.30
Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components. J Exp Med (1968) 4.19
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol (1997) 3.79
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol (2001) 3.55
Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 3.55
Mutual information without the influence of phylogeny or entropy dramatically improves residue contact prediction. Bioinformatics (2007) 3.42
Macrophages as a source of tumoricidal activity (tumor-necrotizing factor). Infect Immun (1980) 3.41
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis. Cell Immunol (1984) 3.36
Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes. J Exp Med (1968) 3.33
Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol (1978) 3.16
Collagenase production by endotoxin-activated macrophages. Proc Natl Acad Sci U S A (1974) 3.05
Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor. Infect Immun (1970) 3.01
Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest (1991) 3.00
Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes. Science (1972) 2.91
Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens. J Exp Med (1967) 2.87
Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol (1988) 2.70
Collagenase production by lymphokine-activated macrophages. Science (1975) 2.64
Electron microscopic localization of endotoxic lipopolysaccharide in gram-negative organisms. Ann N Y Acad Sci (1966) 2.61
Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today (1989) 2.56
A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin. J Immunol (1969) 2.54
Using information theory to search for co-evolving residues in proteins. Bioinformatics (2005) 2.53
Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39
The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol (1968) 2.38
Regulation of murine macrophage Ia-antigen expression by products of activated spleen cells. J Exp Med (1980) 2.19
A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes. J Immunol (1973) 2.18
Significance of complement to the mechanism of action of endotoxin. Curr Top Microbiol Immunol (1969) 2.18
Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates. J Exp Med (1971) 2.15
Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells. Infect Immun (1980) 2.12
The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J Infect Dis (1980) 2.11
Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors. J Immunol (1980) 2.04
Tumor-associated macrophages as targets for cancer therapy. J Natl Cancer Inst (1998) 2.01
Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci U S A (1977) 1.96
Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/56lyn. J Biol Chem (1993) 1.95
Lesions in Escherichia coli membranes after action of antibody and complement. J Bacteriol (1966) 1.94
Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes. J Immunol (1972) 1.90
Interactions of the complement system with native and chemically modified endotoxins. J Bacteriol (1968) 1.87
The pathogenesis of group A streptococcal cell wall-induced polyarthritis in the rat. Comparative studies in arthritis resistant and susceptible inbred rat strains. Arthritis Rheum (1983) 1.83
Decreased properdin activity in acute glomerulonephritis. Int Arch Allergy Appl Immunol (1969) 1.83
Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med (2001) 1.80
BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies. J Immunol (1980) 1.74
Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens. J Exp Med (1979) 1.73
Improving estimates of the basic reproductive ratio: using both the mean and the dispersal of transition times. Theor Popul Biol (2006) 1.71
Elevated gamma-globulin and increased antibody production in mice infected with lactic dehydrogenase virus. J Exp Med (1966) 1.71
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci U S A (1996) 1.68
Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J Clin Invest (1997) 1.67
Factors from saliva and oral bacteria, chemotactic for polymorphonuclear leukocytes: their possible role in gingival inflammation. J Periodontol (1970) 1.66
Biologic properties of chromatographically separated murine thymoma-derived Interleukin 2 and colony-stimulating factor. J Immunol (1981) 1.65
Importance of Actinomyces and certain gram-negative anaerobic organisms in the transformation of lymphocytes from patients with periodontal disease. Infect Immun (1976) 1.62
In vitro transformation of mouse bone-marrow-derived (B) lymphocytes induced by the lipid component of endotoxin. Infect Immun (1973) 1.62
Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. Science (1984) 1.61
Macrophage-lymphocyte synergy in the production of osteoclast activating factor. J Immunol (1974) 1.61
Complement-dependent biological functions in complement deficiency in man. Lancet (1966) 1.56
Resistance of macrophages from C3H/HeJ mice to the in vitro cytotoxic effects of endotoxin. J Immunol (1977) 1.56
Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med (1991) 1.55
Mandibular condyle position: comparison of articulator mountings and magnetic resonance imaging. Am J Orthod Dentofacial Orthop (1993) 1.54
The fixation probability of beneficial mutations. J R Soc Interface (2008) 1.52
Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem (1992) 1.46
In vitro studies of a chemotactic lymphokine in the guinea pig. Int Arch Allergy Appl Immunol (1974) 1.46
Biosynthetic thiolase from zoogloea ramigera. I. Preliminary characterization and analysis of proton transfer reaction. J Biol Chem (1987) 1.44
Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo. Infect Immun (1976) 1.44
Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol (1999) 1.42
Pentoxifylline improves bacterial clearance during hemorrhage and endotoxemia. Crit Care Med (1999) 1.42
Decreased C'-1q protein concentration and agglutinating activity in agammaglobulinaemia syndromes: an inborn error reflected in the complement system. Clin Exp Immunol (1968) 1.41
Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J Immunol (1987) 1.40
Type 2 fimbrial lectin-mediated phagocytosis of oral Actinomyces spp. by polymorphonuclear leukocytes. Infect Immun (1986) 1.40
HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol (1989) 1.34
Complement-dependent stimulation of prostaglandin synthesis and bone resorption. Science (1974) 1.31
Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor. J Immunol (1988) 1.30
Differential endotoxin sensitivity of lymphocytes and macrophages from mice with an X-linked defect in B cell maturation. J Immunol (1978) 1.30
Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. J Virol (1984) 1.29
T lymphocyte-dependent evolution of bacterial cell wall-induced hepatic granulomas. J Immunol (1986) 1.29
The function and distribution of different fimbriae on strains of Actinomyces viscosus and Actinomyces naeslundii. J Dent Res (1984) 1.27
Bactericidal antibody in mammalian serum to obligatorily anaerobic Gram-negative bacteria. J Immunol (1966) 1.27
Interactions of the complement system with endotoxins from a Salmonella minnesota mutant deficient in O-polysaccharide and heptose. J Immunol (1968) 1.27
Inflammation and herpes simplex virus: release of a chemotaxis-generating factor from infected cells. Science (1970) 1.27
Increased thymocyte-activating factor in human gingival fluid during gingival inflammation. Infect Immun (1982) 1.27
Apoptosis in human monocytes: possible role in chronic inflammatory diseases. J Periodontol (1993) 1.26
Humoral mediators of chemotaxis of mononuclear leukocytes. J Infect Dis (1972) 1.26
Macrophage sensitivity to endotoxin: genetic control by a single codominant gene. J Immunol (1978) 1.26
Hepatic fibrosis in schistosomiasis: egg granulomas secrete fibroblast stimulating factor in vitro. Science (1978) 1.25
Inhibition of cellular immune reactions in mice infected with lactic dehydrogenase virus. Nature (1969) 1.25
Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes. Am J Reprod Immunol (2001) 1.24
BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. II. T cell modulation of macrophage sensitivity to LPS in vitro. Immunobiology (1982) 1.23
A longitudinal study of anteroposterior growth changes in the palatine rugae. J Dent Res (1987) 1.23
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). II. Functional properties of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions. Cell Immunol (1984) 1.22
Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors. J Immunol (1987) 1.22